Skip to main content

MoneyWorks4Me

Zydus Lifesciences informs about press release

13 Nov 2025 Evaluate
Zydus Lifesciences has informed that it enclosed a copy of press release dated November 13, 2025, titled ‘Zydus receives final approval from USFDA for Diroximel Fumarate Delayed-Release Capsules, 231 mg’.

The above information is a part of company’s filings submitted to BSE.
Peers
Company Name CMP
Sun Pharma. Inds. 1905.00
Dr. Reddys Labs. 1385.00
Cipla 1406.00
Lupin 2012.00
Zydus Lifesciences 1213.05
View more..